DiaMedica Therapeutics Inc.

DMAC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Mar 28, 2025 FORM DEFA14A
DEF 14A Mar 28, 2025 FORM DEF 14A
10-K Mar 17, 2025 FORM 10-K
8-K Mar 17, 2025 FORM 8-K
8-K Mar 6, 2025 FORM 8-K
4 Feb 24, 2025 PRIMARY DOCUMENT
3 Feb 24, 2025 PRIMARY DOCUMENT
8-K Feb 24, 2025 FORM 8-K
4 Feb 18, 2025 PRIMARY DOCUMENT
4 Jan 3, 2025 PRIMARY DOCUMENT
4 Jan 3, 2025 PRIMARY DOCUMENT
4 Jan 3, 2025 PRIMARY DOCUMENT
4 Jan 3, 2025 PRIMARY DOCUMENT
4 Jan 3, 2025 PRIMARY DOCUMENT
10-Q Nov 13, 2024 FORM 10-Q
8-K Nov 13, 2024 FORM 8-K
8-K Aug 7, 2024 FORM 8-K
10-Q Aug 7, 2024 FORM 10-Q
EFFECT Jul 18, 2024
424B3 Jul 18, 2024 FORM 424B3
CORRESP Jul 16, 2024
UPLOAD Jul 15, 2024
S-3 Jul 10, 2024 FORM S-3
SC 13G Jul 8, 2024
D Jul 2, 2024
← Newer Page 4 of 18 · 427 filings Older →